CRESCENT BIOPHARMA, INC.

Regulatory Filings • May 23, 2019

CORRESP 1 filename1.htm

May 23, 2019

VIA EDGAR

Ms. Christine Westbrook

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

*Re: GlycoMimetics, Inc. (the “ Registrant ”)*

*Registration Statement on Form S-3, File No. 333-231577*

*Acceleration Request*

*Requested Date: Tuesday, May 28, 2019*

*Requested Time: 4:00 p.m. Eastern Time*

Dear Ms. Westbrook:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ *Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-231577) (the “ Registration Statement ”) to become effective on Tuesday, May 28, 2019, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “ Staff*** ”).

Once the Registration Statement has been declared effective, please orally confirm that event with Katie Kazem of Cooley LLP, counsel to the Registrant, at (703) 456-8043, or in her absence, Brian Leaf at (703) 456-8053.

Very truly yours,
GLYCOMIMETICS, INC.
By:	/s/ Brian M. Hahn
	Brian M. Hahn
	Chief Financial Officer

SEQ.=1,FOLIO='',FILE='C:\JMS\C905664\19-9820-3\task9371142\9820-3-bc.htm',USER='C905664',CD='May 24 00:16 2019'